|
Market Closed -
NYSE
04:02:41 14/08/2026 HKT
|
After hours 04:53:30 | |||
| 144.26 USD | +0.12% |
|
144.54 | +0.20% |
| 08-10 | Berenberg Adjusts Price Target on Procter & Gamble to $143 From $146, Maintains Hold Rating | MT |
| 08-07 | US wellness shot brand Dose explores sale, sources say | RE |
Company Valuation: Procter & Gamble Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 344,995 | 357,647 | 389,234 | 373,532 | 341,466 | 334,904 | - | - |
| Change | - | 3.67% | 8.83% | -4.03% | -8.58% | -1.92% | - | - |
| Enterprise Value (EV) 1 | 369,274 | 384,008 | 412,212 | 398,484 | 365,662 | 359,336 | 358,271 | 356,568 |
| Change | - | 3.99% | 7.34% | -3.33% | -8.24% | -1.73% | -0.3% | -0.48% |
| P/E | 24.7x | 25.7x | 27.4x | 24.5x | 22.2x | 21x | 19.5x | 18.6x |
| PBR | 7.35x | 7.66x | 8.06x | 7.48x | 6.54x | 6.09x | 5.86x | 5.59x |
| PEG | - | 16.59x | 13.47x | 3.01x | 13.14x | 5.45x | 2.65x | 3.95x |
| Capitalization / Revenue | 4.3x | 4.36x | 4.63x | 4.43x | 3.92x | 3.77x | 3.66x | 3.54x |
| EV / Revenue | 4.61x | 4.68x | 4.91x | 4.73x | 4.2x | 4.05x | 3.92x | 3.77x |
| EV / EBITDA | 17.9x | 18.4x | 18x | 17.1x | 15.5x | 14.8x | 14x | 13.3x |
| EV / EBIT | 20.7x | 21.2x | 20.6x | 19.5x | 17.8x | 17.1x | 16.2x | 15.4x |
| EV / FCF | 27.2x | 27.9x | 24.9x | 27.3x | 24.1x | 22.9x | 21.6x | 20.2x |
| FCF Yield | 3.67% | 3.59% | 4.01% | 3.67% | 4.14% | 4.37% | 4.63% | 4.96% |
| Dividend per Share 2 | 3.523 | 3.681 | 3.829 | 4.076 | 4.259 | 4.412 | 4.608 | 4.826 |
| Rate of return | 2.45% | 2.43% | 2.32% | 2.56% | 2.9% | 3.06% | 3.2% | 3.35% |
| EPS 2 | 5.81 | 5.9 | 6.02 | 6.51 | 6.62 | 6.875 | 7.381 | 7.728 |
| Distribution rate | 60.6% | 62.4% | 63.6% | 62.6% | 64.3% | 64.2% | 62.4% | 62.4% |
| Net sales 1 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 | 88,745 | 91,481 | 94,561 |
| EBITDA 1 | 20,620 | 20,848 | 22,884 | 23,303 | 23,657 | 24,347 | 25,606 | 26,817 |
| EBIT 1 | 17,813 | 18,134 | 19,988 | 20,456 | 20,497 | 20,990 | 22,055 | 23,116 |
| Net income 1 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 | 16,539 | 17,558 | 18,265 |
| Net Debt 1 | 24,279 | 26,361 | 22,978 | 24,952 | 24,196 | 24,432 | 23,366 | 21,664 |
| Reference price 2 | 143.79 | 151.74 | 164.92 | 159.32 | 146.64 | 144.08 | 144.08 | 144.08 |
| Nbr of stocks (in thousands) | 2,399,297 | 2,356,969 | 2,360,135 | 2,344,542 | 2,328,599 | 2,324,433 | - | - |
| Announcement Date | 29/7/22 | 28/7/23 | 30/7/24 | 29/7/25 | 29/7/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.96x | 4.05x | 14.76x | 3.06% | 335B | |
| 17.85x | 2.69x | 11.87x | 3.58% | 133B | |
| 25.11x | 3.75x | 15.77x | 2.3% | 73.59B | |
| 42.79x | 6.89x | 29.91x | 2.16% | 50.82B | |
| 19.96x | 2.79x | 11.68x | 4.46% | 36.46B | |
| 84.8x | 2.5x | 15.05x | 1.6% | 31.72B | |
| 24.1x | 1.78x | 11.34x | 2.12% | 20.96B | |
| 20.79x | 1.35x | 8.71x | 1.27% | 19.84B | |
| 15.89x | 1.53x | 8.71x | 3.33% | 19.55B | |
| 38.98x | 5.5x | 26.96x | 1.87% | 9.76B | |
| Average | 31.12x | 3.28x | 15.48x | 2.57% | 73.05B | |
| Weighted average by Cap. | 25.24x | 3.65x | 14.99x | 2.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PG Stock
- Valuation Procter & Gamble Company
Select your edition
All financial news and data tailored to specific country editions
